KR102082768B1 - 핵산 제조 방법 - Google Patents

핵산 제조 방법 Download PDF

Info

Publication number
KR102082768B1
KR102082768B1 KR1020197003483A KR20197003483A KR102082768B1 KR 102082768 B1 KR102082768 B1 KR 102082768B1 KR 1020197003483 A KR1020197003483 A KR 1020197003483A KR 20197003483 A KR20197003483 A KR 20197003483A KR 102082768 B1 KR102082768 B1 KR 102082768B1
Authority
KR
South Korea
Prior art keywords
leu
ala
pro
thr
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197003483A
Other languages
English (en)
Korean (ko)
Other versions
KR20190016132A (ko
Inventor
아르바이다스 자누라이티스
레미지 주스 스키르가일라
단기라 식스니에네
Original Assignee
써모 피셔 사이언티픽 발틱스 유에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 써모 피셔 사이언티픽 발틱스 유에이비 filed Critical 써모 피셔 사이언티픽 발틱스 유에이비
Publication of KR20190016132A publication Critical patent/KR20190016132A/ko
Application granted granted Critical
Publication of KR102082768B1 publication Critical patent/KR102082768B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1075Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020197003483A 2008-04-10 2009-04-09 핵산 제조 방법 Active KR102082768B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0806562.5A GB0806562D0 (en) 2008-04-10 2008-04-10 Production of nucleic acid
GB0806562.5 2008-04-10
PCT/EP2009/054329 WO2009125006A2 (en) 2008-04-10 2009-04-09 Production of nucleic acid

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020187003649A Division KR101947101B1 (ko) 2008-04-10 2009-04-09 핵산 제조 방법

Publications (2)

Publication Number Publication Date
KR20190016132A KR20190016132A (ko) 2019-02-15
KR102082768B1 true KR102082768B1 (ko) 2020-02-28

Family

ID=39433452

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020167013385A Active KR101828902B1 (ko) 2008-04-10 2009-04-09 핵산 제조 방법
KR1020187003649A Active KR101947101B1 (ko) 2008-04-10 2009-04-09 핵산 제조 방법
KR1020197003483A Active KR102082768B1 (ko) 2008-04-10 2009-04-09 핵산 제조 방법
KR1020107025153A Active KR101653775B1 (ko) 2008-04-10 2009-04-09 핵산 제조 방법

Family Applications Before (2)

Application Number Title Priority Date Filing Date
KR1020167013385A Active KR101828902B1 (ko) 2008-04-10 2009-04-09 핵산 제조 방법
KR1020187003649A Active KR101947101B1 (ko) 2008-04-10 2009-04-09 핵산 제조 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020107025153A Active KR101653775B1 (ko) 2008-04-10 2009-04-09 핵산 제조 방법

Country Status (14)

Country Link
US (5) US8835148B2 (enExample)
EP (4) EP3098308B1 (enExample)
JP (5) JP5642662B2 (enExample)
KR (4) KR101828902B1 (enExample)
CN (2) CN107058258A (enExample)
AU (1) AU2009235368B2 (enExample)
CA (1) CA2721117A1 (enExample)
ES (1) ES2647272T3 (enExample)
GB (1) GB0806562D0 (enExample)
IL (2) IL208578A (enExample)
NZ (1) NZ588468A (enExample)
PL (1) PL2281035T3 (enExample)
SG (1) SG10201503327QA (enExample)
WO (1) WO2009125006A2 (enExample)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9771565B2 (en) * 2000-05-26 2017-09-26 Life Technologies Corporation Thermostable reverse transcriptases and uses thereof
US20040209276A1 (en) 2002-09-13 2004-10-21 Smith Michael D. Thermostable reverse transcriptases and uses thereof
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
GB0806562D0 (en) 2008-04-10 2008-05-14 Fermentas Uab Production of nucleic acid
ES2628739T3 (es) * 2009-10-15 2017-08-03 Ibis Biosciences, Inc. Amplificación por desplazamiento múltiple
US8900814B2 (en) 2010-08-13 2014-12-02 Kyoto University Variant reverse transcriptase
KR101818126B1 (ko) * 2011-02-09 2018-01-15 (주)바이오니아 열안정성이 증가된 역전사효소
JP6261500B2 (ja) 2011-07-22 2018-01-17 プレジデント アンド フェローズ オブ ハーバード カレッジ ヌクレアーゼ切断特異性の評価および改善
US9745571B2 (en) * 2013-03-07 2017-08-29 Bio-Rad Laboratories, Inc. Repetitive reverse transcription partition assay
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
WO2015075842A1 (ja) * 2013-11-25 2015-05-28 国立大学法人京都大学 変異型逆転写酵素
US9068179B1 (en) 2013-12-12 2015-06-30 President And Fellows Of Harvard College Methods for correcting presenilin point mutations
KR20160113177A (ko) * 2014-01-22 2016-09-28 라이프 테크놀로지스 코포레이션 고온 핵산 합성에서 이용하기 위한 신규한 역전사효소
CN106414704B (zh) 2014-03-14 2020-11-03 生命技术公司 用于核酸扩增和检测的集成系统
CN104250642A (zh) * 2014-04-30 2014-12-31 厦门安普利生物工程有限公司 一种提取纯化m-mlv逆转录酶的方法
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
KR102333255B1 (ko) 2015-05-11 2021-12-01 일루미나, 인코포레이티드 치료제의 발견 및 분석을 위한 플랫폼
EP3365356B1 (en) 2015-10-23 2023-06-28 President and Fellows of Harvard College Nucleobase editors and uses thereof
EP3443079A1 (en) 2016-04-12 2019-02-20 Solis Biodyne Synthetic reverse transcriptases and uses thereof
JP7231935B2 (ja) 2016-08-03 2023-03-08 プレジデント アンド フェローズ オブ ハーバード カレッジ アデノシン核酸塩基編集因子およびそれらの使用
EP3497214B1 (en) 2016-08-09 2023-06-28 President and Fellows of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
US9580698B1 (en) * 2016-09-23 2017-02-28 New England Biolabs, Inc. Mutant reverse transcriptase
EP3526320A1 (en) 2016-10-14 2019-08-21 President and Fellows of Harvard College Aav delivery of nucleobase editors
US11220677B2 (en) 2016-12-14 2022-01-11 Takara Bio Inc. Heat-resistant reverse transcriptase mutant
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
WO2018165631A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Cancer vaccine
KR20190127797A (ko) 2017-03-10 2019-11-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 시토신에서 구아닌으로의 염기 편집제
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
CN110709513B (zh) 2017-04-11 2023-10-03 豪夫迈·罗氏有限公司 具有热稳定性增加的突变型逆转录酶以及涉及其的产物、方法和用途
US20180312822A1 (en) * 2017-04-26 2018-11-01 10X Genomics, Inc. Mmlv reverse transcriptase variants
WO2018200867A1 (en) * 2017-04-26 2018-11-01 10X Genomics, Inc. Mmlv reverse transcriptase variants
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
WO2019023680A1 (en) 2017-07-28 2019-01-31 President And Fellows Of Harvard College METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
WO2019051097A1 (en) 2017-09-08 2019-03-14 The Regents Of The University Of California RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME
CN111757937A (zh) 2017-10-16 2020-10-09 布罗德研究所股份有限公司 腺苷碱基编辑器的用途
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
CN111556900A (zh) 2017-12-22 2020-08-18 赛默飞世尔科技波罗的海封闭股份公司 包括胺的聚合酶链反应组合物
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
US12188014B1 (en) 2018-07-25 2025-01-07 10X Genomics, Inc. Compositions and methods for nucleic acid processing using blocking agents
WO2020077236A1 (en) * 2018-10-12 2020-04-16 The Broad Institute, Inc. Method for extracting nuclei or whole cells from formalin-fixed paraffin-embedded tissues
US12281338B2 (en) 2018-10-29 2025-04-22 The Broad Institute, Inc. Nucleobase editors comprising GeoCas9 and uses thereof
CN112969527A (zh) * 2018-11-08 2021-06-15 深圳华大生命科学研究院 一种微流控芯片及其制备方法和dna合成方法
CN113785053B (zh) * 2018-12-26 2024-07-12 深圳华大生命科学研究院 酶活性提高的逆转录酶及其应用
WO2020154500A1 (en) 2019-01-23 2020-07-30 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
MX2021011426A (es) 2019-03-19 2022-03-11 Broad Inst Inc Metodos y composiciones para editar secuencias de nucleótidos.
EP3956349A1 (en) 2019-04-17 2022-02-23 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US20220290112A1 (en) * 2019-07-26 2022-09-15 Toyobo Co., Ltd. Variant reverse transcriptase exhibiting excellent stability
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
CA3157359A1 (en) 2019-10-10 2021-04-15 1859, Inc. Methods and systems for microfluidic screening
CN112795551B (zh) * 2019-11-13 2024-01-30 广州达安基因股份有限公司 一种耐高温逆转录酶突变体及其应用
CN112795547B (zh) * 2019-11-13 2024-05-31 广州达安基因股份有限公司 高逆转录效率的逆转录酶突变体
CN112795548A (zh) * 2019-11-13 2021-05-14 中山大学达安基因股份有限公司 具有高逆转录效率的耐高温逆转录酶突变体及其应用
CN112795549B (zh) * 2019-11-13 2023-11-28 广州达安基因股份有限公司 一种逆转录酶突变体
CN112795546B (zh) * 2019-11-13 2024-02-27 广州达安基因股份有限公司 一种具有高逆转录效率的耐高温逆转录酶突变体及其应用
WO2021119320A2 (en) 2019-12-11 2021-06-17 10X Genomics, Inc. Reverse transcriptase variants
US20230357784A1 (en) 2020-02-21 2023-11-09 Limagrain Europe Prime editing technology for plant genome engineering
WO2021188840A1 (en) * 2020-03-19 2021-09-23 Rewrite Therapeutics, Inc. Methods and compositions for directed genome editing
MX2022014008A (es) 2020-05-08 2023-02-09 Broad Inst Inc Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo.
CN111849938B (zh) * 2020-06-05 2022-02-15 广州英赞生物科技有限公司 一种突变型逆转录酶及其制备方法与应用
CN111647576B (zh) * 2020-06-24 2021-02-09 南京诺唯赞生物科技股份有限公司 一种热稳定性逆转录酶突变体及其应用
WO2022020371A2 (en) * 2020-07-20 2022-01-27 Integrated Dna Technologies, Inc. Reverse transcriptase mutants with increased activity and thermostability
CN114480330B (zh) * 2020-11-13 2024-11-01 广州达安基因股份有限公司 多突变位点的逆转录酶突变体
CN114480332B (zh) * 2020-11-13 2023-12-05 广州达安基因股份有限公司 耐高温m-mlv酶突变体及其应用
CN114480336B (zh) * 2020-11-13 2023-10-20 广州达安基因股份有限公司 含有逆转录酶突变体的核酸检测试剂盒
CN114480331A (zh) * 2020-11-13 2022-05-13 广州达安基因股份有限公司 Mmlv酶组合突变体
CN114480335B (zh) * 2020-11-13 2024-06-07 广州达安基因股份有限公司 逆转录酶及逆转录检测试剂
US20240002818A1 (en) * 2020-11-24 2024-01-04 Saliogen Therapeutics, Inc. Mammalian mobile element compositions, systems and therapeutic applications
CN112481234B (zh) * 2020-12-03 2023-09-22 重庆工业职业技术学院 一种焦磷酸酶突变体合成核酸糖类似物及其应用
CN112251423B (zh) * 2020-12-08 2021-03-19 北京健为医学检验实验室有限公司 一种m-mlv逆转录酶体及其应用
CN113234858A (zh) * 2021-05-20 2021-08-10 阿吉安(福州)基因医学检验实验室有限公司 一种covid-19的检测试剂盒
IL308469A (en) * 2021-05-26 2024-01-01 Etherna Immunotherapies Nv Method to reduce double stranded rna by-product formation
CN113174381B (zh) * 2021-06-08 2023-05-12 翌圣生物科技(上海)股份有限公司 增强型mmlv逆转录酶突变体及其应用
EP4450619A4 (en) * 2021-12-17 2025-06-25 Toyobo Co., Ltd. Reverse transcriptase having excellent thermal stability
CN114214299A (zh) * 2022-01-26 2022-03-22 苏州译酶生物科技有限公司 一种m-mlv逆转录酶及其制备方法
CN114657165B (zh) * 2022-03-25 2023-04-07 江苏百时美生物科技有限公司 一种提高热稳定性和抑制剂耐受性的逆转录酶突变体及其应用
CN114591930B (zh) * 2022-05-10 2022-08-12 翌圣生物科技(上海)股份有限公司 增强型逆转录酶、编码dna、试剂盒及其在rna文库构建中的应用
CN117106746B (zh) * 2022-06-01 2024-11-22 北京擎科生物科技股份有限公司 逆转录突变体及其应用
CN116064460B (zh) * 2022-08-01 2023-09-26 南京诺唯赞生物科技股份有限公司 一种mmlv突变体及其应用
CN117586983A (zh) * 2022-08-11 2024-02-23 菲鹏生物股份有限公司 一种逆转录酶、核酸分子及合成cDNA的方法
CN115747186B (zh) * 2022-09-13 2025-05-27 天罗诊断科技江苏有限公司 一种耐热的高效率逆转录酶突变体及其应用
CN116042569B (zh) * 2023-02-01 2023-08-15 珠海宝锐生物科技有限公司 Mmlv逆转录酶突变体及其应用
CN116004568B (zh) * 2023-02-07 2025-10-17 北京诺派生物科技有限公司 一种可用于核酸检测的耐高温反转录酶及其制备方法与应用
WO2024211850A1 (en) * 2023-04-05 2024-10-10 Primrose Bio, Inc. Methods and compositions for protein engineering
CN116622669B (zh) * 2023-06-30 2024-06-07 翌圣生物科技(上海)股份有限公司 一种鼠白血病病毒逆转录酶突变体及其应用
CN119506243A (zh) * 2023-06-30 2025-02-25 翌圣生物科技(上海)股份有限公司 一种鼠白血病病毒逆转录酶突变体及其应用
CN116732141B (zh) * 2023-07-10 2024-04-02 海南大学 一种快速检测生物dna特异性的方法
CN117025724A (zh) * 2023-08-23 2023-11-10 翌圣生物科技(上海)股份有限公司 Rna链特异性建库试剂盒及建库方法
CN117925558B (zh) * 2023-12-13 2025-03-25 郑州玛特瑞斯生物科技有限公司 突变型逆转录酶及其应用
CN118406670B (zh) * 2024-05-06 2025-06-27 湖南艾科瑞生物工程有限公司 一种mmlv逆转录酶突变体及其应用
CN119955759B (zh) * 2025-01-07 2025-08-08 湖南艾科瑞生物工程有限公司 一种mmlv逆转录酶突变体及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101653775B1 (ko) * 2008-04-10 2016-09-05 써모 피셔 사이언티픽 발틱스 유에이비 핵산 제조 방법

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6236563A (ja) 1985-08-12 1987-02-17 Koji Ando 可動導体型計器
US5244797B1 (en) 1988-01-13 1998-08-25 Life Technologies Inc Cloned genes encoding reverse transcriptase lacking rnase h activity
JP3127158B2 (ja) 1989-10-05 2001-01-22 オプテイン,インコーポレイティド 新規の遺伝子及びポリペチドの無細胞合成並びに単離
US6183967B1 (en) * 1995-06-07 2001-02-06 Nexstar Pharmaceuticals Nucleic acid ligand inhibitors to DNA polymerases
WO1998023733A2 (en) 1996-11-27 1998-06-04 University Of Washington Thermostable polymerases having altered fidelity
EP2184289A1 (en) 1997-04-22 2010-05-12 Life Technologies Corporation Methods for the production of ASLV reverse transcriptases composed of multiple subunits
DE69826697T2 (de) 1997-07-07 2006-02-16 Medical Research Council In vitro selektionsmethode
US6136582A (en) 1998-01-20 2000-10-24 The Trustees Of Columbia University In The City Reverse transcriptase of moloney murine leukemia virus with RNA polymerase activity
JP4193079B2 (ja) 1998-11-10 2008-12-10 東洋紡績株式会社 変異型逆転写酵素
CA2359538A1 (en) * 1999-01-15 2000-07-20 Neela Swaminathan Biologically active reverse transcriptases
CA2401417A1 (en) 2000-03-15 2001-09-20 Invitrogen Corporation High fidelity reverse transcriptases and uses thereof
EP1268766B1 (en) 2000-03-31 2005-11-30 Cambridge Antibody Technology Limited Improvements to ribosome display
US20040209276A1 (en) 2002-09-13 2004-10-21 Smith Michael D. Thermostable reverse transcriptases and uses thereof
EP1290149A4 (en) 2000-05-26 2004-03-17 Invitrogen Corp THERMOSTABLE INVERTED TRANSCRIPTASES AND USES
US7078208B2 (en) 2000-05-26 2006-07-18 Invitrogen Corporation Thermostable reverse transcriptases and uses thereof
GB0022458D0 (en) 2000-09-13 2000-11-01 Medical Res Council Directed evolution method
WO2003025132A2 (en) 2001-09-14 2003-03-27 Invitrogen Corporation Dna polymerases and mutants thereof
GB0127564D0 (en) * 2001-11-16 2002-01-09 Medical Res Council Emulsion compositions
GB2388031B (en) 2002-04-30 2005-07-27 Abbott Lab A lancet removal tool
EP2385118A1 (en) * 2002-09-06 2011-11-09 Isogenica Limited In vitro peptide expression library
GB0221053D0 (en) 2002-09-11 2002-10-23 Medical Res Council Single-molecule in vitro evolution
EP1691792A4 (en) * 2003-11-24 2008-05-28 Yeda Res & Dev COMPOSITIONS AND PROCESSES FOR SORTING IN VITRO OF MOLECULE AND CELL LIBRARIES
WO2005071072A1 (en) 2004-01-13 2005-08-04 The Institute Of Biophysics Chinese Academy Of Sciences The recombinant murine leukemia virus reverse transcriptase, the gene encoding it and the method for expressing it
US7595179B2 (en) 2004-04-19 2009-09-29 Applied Biosystems, Llc Recombinant reverse transcriptases
US20080004436A1 (en) 2004-11-15 2008-01-03 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Directed Evolution and Selection Using in Vitro Compartmentalization
JPWO2007011045A1 (ja) * 2005-07-20 2009-02-05 株式会社クラレ パージング剤
CA2617790A1 (en) * 2005-08-10 2007-02-22 Stratagene California Mutant reverse transcriptase and methods of use
DK2074211T3 (da) 2006-09-06 2013-06-17 Medical Res Council DNA polymeraser til inkorporation af farvestof-mærkede nukleotid-analoger

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101653775B1 (ko) * 2008-04-10 2016-09-05 써모 피셔 사이언티픽 발틱스 유에이비 핵산 제조 방법
KR101828902B1 (ko) * 2008-04-10 2018-02-13 써모 피셔 사이언티픽 발틱스 유에이비 핵산 제조 방법
KR101947101B1 (ko) * 2008-04-10 2019-02-12 써모 피셔 사이언티픽 발틱스 유에이비 핵산 제조 방법

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J Virol. 2006 Sep;80(17):8379-89.
J Virol. 2007 Nov;81(22):12337-47.

Also Published As

Publication number Publication date
EP3098308A1 (en) 2016-11-30
US20110065606A1 (en) 2011-03-17
US8835148B2 (en) 2014-09-16
US10358670B2 (en) 2019-07-23
CN107058258A (zh) 2017-08-18
KR101947101B1 (ko) 2019-02-12
IL208578A0 (en) 2010-12-30
US20180298414A1 (en) 2018-10-18
US20130288925A1 (en) 2013-10-31
CA2721117A1 (en) 2009-10-15
KR20180016635A (ko) 2018-02-14
AU2009235368B2 (en) 2014-01-16
KR20160062213A (ko) 2016-06-01
JP6140792B2 (ja) 2017-05-31
JP2016073298A (ja) 2016-05-12
EP2639300A3 (en) 2014-03-26
JP2014158473A (ja) 2014-09-04
EP2639300B1 (en) 2017-08-09
KR20190016132A (ko) 2019-02-15
US20170298403A1 (en) 2017-10-19
JP2018046841A (ja) 2018-03-29
WO2009125006A3 (en) 2010-03-11
AU2009235368A1 (en) 2009-10-15
JP6236563B2 (ja) 2017-11-22
EP3098308B1 (en) 2018-11-14
PL2281035T3 (pl) 2015-07-31
US8580548B2 (en) 2013-11-12
NZ588468A (en) 2012-10-26
KR101653775B1 (ko) 2016-09-05
JP2011516072A (ja) 2011-05-26
EP3375870A1 (en) 2018-09-19
SG10201503327QA (en) 2015-06-29
US10287614B2 (en) 2019-05-14
KR101828902B1 (ko) 2018-02-13
GB0806562D0 (en) 2008-05-14
JP5642662B2 (ja) 2014-12-17
WO2009125006A2 (en) 2009-10-15
US20120156752A1 (en) 2012-06-21
KR20110065420A (ko) 2011-06-15
JP6473795B2 (ja) 2019-02-20
IL246396B (en) 2018-04-30
EP3375870B1 (en) 2020-08-05
CN102057039A (zh) 2011-05-11
US9683251B2 (en) 2017-06-20
EP2281035B1 (en) 2015-01-21
IL208578A (en) 2016-07-31
EP2639300A2 (en) 2013-09-18
ES2647272T3 (es) 2017-12-20
JP2017169575A (ja) 2017-09-28
EP2281035A2 (en) 2011-02-09

Similar Documents

Publication Publication Date Title
US10358670B2 (en) Production of nucleic acid
ES2914591T3 (es) Procedimientos novedosos para la producción de oligonucleótidos
CN112831484B (zh) T7-rna聚合酶突变体及其应用
JP2024028958A (ja) 不連続な複数の鋳型から相補的DNA(cDNA)を順序だてて連続的に合成するための組成物およびその方法
ES2889548T3 (es) Método para introducir mutaciones
EP3354736B1 (en) Promoter construct for cell-free protein synthesis

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20190201

Application number text: 1020187003649

Filing date: 20180206

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190226

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190503

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20191125

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20200224

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20200224

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20230221

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20240222

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20250211

Start annual number: 6

End annual number: 6